Targeting EZH2 in Multiple Myeloma Could be Promising for a Subgroup of MM Patients in Combination with IMiDs

被引：7

作者：

Herviou, Laurie ^{[1
]}

Kassambara, Alboukadel ^{[2
]}

Boireau, Stephanie ^{[3
]}

Robert, Nicolas ^{[3
]}

Requirand, Guilhem ^{[3
]}

Vincent, Laure ^{[4
]}

Seckinger, Anja ^{[5
,6
]}

Goldschmidt, Hartmut ^{[7
]}

Hose, Dirk ^{[5
]}

Cavalli, Giacomo ^{[1
]}

Moreaux, Jerome ^{[1
,8
]}

机构：

[1] CNRS UPR 1142, Inst Human Genet, Montpellier, France

[2] Univ Hosp Montpellier, CNRS UPR1142, Inst Human Genet, Montpellier, France

[3] Univ Hosp Montpellier, Montpellier, France

[4] CHU Montpellier, Dept Clin Haematol, Montpellier, France

[5] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany

[6] Heidelberg Univ, Dept Internal Med, Hematol Oncol, Heidelberg, Germany

[7] Heidelberg Univ, Dept Med 5, Heidelberg, Germany

[8] Univ Hosp Montpellier, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France

来源：

关键词：

D O I：

10.1182/blood.V128.22.311.311

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

311

引用

页数：4